SANGAMO THERAPEUTICS FRANCE;THE UNIVERSITY OF BRITISH COLUMBIA
发明人:
Li ZHOU,Tobias ABEL,François MEYER,Megan LEVINGS,Nicolas DAWSON,Caroline LAMARCHE
申请号：
US16649426
公开号：
US20200283530A1
申请日:
2018.09.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a novel anti-HLA-A2 antibody, and to a chimeric antigen receptor comprising said HLA-A2 antibody. The present invention further relates to an immune cell expressing said chimeric receptor antigen, and to therapeutic uses thereof, in particular for treating or preventing graft rejection or GVHD.
